List of Tables
Table 1. Global Cancer Treatment Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Cancer Treatment Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Cancer Treatment Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Cancer Treatment Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Cancer Treatment Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Cancer Treatment Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Cancer Treatment Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Cancer Treatment Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Cancer Treatment Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cancer Treatment Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cancer Treatment Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Cancer Treatment Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cancer Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Treatment Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cancer Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Cancer Treatment Drugs Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Cancer Treatment Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Cancer Treatment Drugs Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Cancer Treatment Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Cancer Treatment Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Cancer Treatment Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Cancer Treatment Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Cancer Treatment Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Cancer Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Cancer Treatment Drugs Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Cancer Treatment Drugs Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Cancer Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Cancer Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Cancer Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Cancer Treatment Drugs Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Cancer Treatment Drugs Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Cancer Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Cancer Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Cancer Treatment Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Cancer Treatment Drugs Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Cancer Treatment Drugs Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Cancer Treatment Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Cancer Treatment Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cancer Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Cancer Treatment Drugs Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Cancer Treatment Drugs Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Cancer Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cancer Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Cancer Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Cancer Treatment Drugs Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Cancer Treatment Drugs Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Cancer Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Cancer Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Cancer Treatment Drugs Sales (K Pcs) by Type (2020-2025)
Table 51. Global Cancer Treatment Drugs Sales (K Pcs) by Type (2026-2031)
Table 52. Global Cancer Treatment Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Cancer Treatment Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Cancer Treatment Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Cancer Treatment Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Cancer Treatment Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Cancer Treatment Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Cancer Treatment Drugs Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Cancer Treatment Drugs Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Cancer Treatment Drugs Sales (K Pcs) by Application (2020-2025)
Table 61. Global Cancer Treatment Drugs Sales (K Pcs) by Application (2026-2031)
Table 62. Global Cancer Treatment Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Cancer Treatment Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Cancer Treatment Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Cancer Treatment Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Cancer Treatment Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Cancer Treatment Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Cancer Treatment Drugs Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Cancer Treatment Drugs Price (USD/Pcs) by Application (2026-2031)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Roche Cancer Treatment Drugs Product
Table 74. Roche Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Novartis Cancer Treatment Drugs Product
Table 79. Novartis Recent Developments/Updates
Table 80. Celgene Company Information
Table 81. Celgene Description and Business Overview
Table 82. Celgene Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Celgene Cancer Treatment Drugs Product
Table 84. Celgene Recent Developments/Updates
Table 85. Bristol-Myers Squibb Company Information
Table 86. Bristol-Myers Squibb Description and Business Overview
Table 87. Bristol-Myers Squibb Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Bristol-Myers Squibb Cancer Treatment Drugs Product
Table 89. Bristol-Myers Squibb Recent Developments/Updates
Table 90. Amgen Company Information
Table 91. Amgen Description and Business Overview
Table 92. Amgen Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Amgen Cancer Treatment Drugs Product
Table 94. Amgen Recent Developments/Updates
Table 95. Johnson & Johnson Company Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Johnson & Johnson Cancer Treatment Drugs Product
Table 99. Johnson & Johnson Recent Developments/Updates
Table 100. Pfizer Company Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Pfizer Cancer Treatment Drugs Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Takeda Company Information
Table 106. Takeda Description and Business Overview
Table 107. Takeda Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Takeda Cancer Treatment Drugs Product
Table 109. Takeda Recent Developments/Updates
Table 110. Eli Lilly Company Information
Table 111. Eli Lilly Description and Business Overview
Table 112. Eli Lilly Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Eli Lilly Cancer Treatment Drugs Product
Table 114. Eli Lilly Recent Developments/Updates
Table 115. AstraZeneca Company Information
Table 116. AstraZeneca Description and Business Overview
Table 117. AstraZeneca Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. AstraZeneca Cancer Treatment Drugs Product
Table 119. AstraZeneca Recent Developments/Updates
Table 120. Astellas Company Information
Table 121. Astellas Description and Business Overview
Table 122. Astellas Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Astellas Cancer Treatment Drugs Product
Table 124. Astellas Recent Developments/Updates
Table 125. Merck & Co. Company Information
Table 126. Merck & Co. Description and Business Overview
Table 127. Merck & Co. Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Merck & Co. Cancer Treatment Drugs Product
Table 129. Merck & Co. Recent Developments/Updates
Table 130. Sanofi Company Information
Table 131. Sanofi Description and Business Overview
Table 132. Sanofi Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Sanofi Cancer Treatment Drugs Product
Table 134. Sanofi Recent Developments/Updates
Table 135. Bayer Company Information
Table 136. Bayer Description and Business Overview
Table 137. Bayer Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Bayer Cancer Treatment Drugs Product
Table 139. Bayer Recent Developments/Updates
Table 140. Biogen Idec Company Information
Table 141. Biogen Idec Description and Business Overview
Table 142. Biogen Idec Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. Biogen Idec Cancer Treatment Drugs Product
Table 144. Biogen Idec Recent Developments/Updates
Table 145. Eisai Company Information
Table 146. Eisai Description and Business Overview
Table 147. Eisai Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. Eisai Cancer Treatment Drugs Product
Table 149. Eisai Recent Developments/Updates
Table 150. Teva Company Information
Table 151. Teva Description and Business Overview
Table 152. Teva Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 153. Teva Cancer Treatment Drugs Product
Table 154. Teva Recent Developments/Updates
Table 155. Otsuka Company Information
Table 156. Otsuka Description and Business Overview
Table 157. Otsuka Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 158. Otsuka Cancer Treatment Drugs Product
Table 159. Otsuka Recent Developments/Updates
Table 160. Merck KGaA Company Information
Table 161. Merck KGaA Description and Business Overview
Table 162. Merck KGaA Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 163. Merck KGaA Cancer Treatment Drugs Product
Table 164. Merck KGaA Recent Developments/Updates
Table 165. Ipsen Company Information
Table 166. Ipsen Description and Business Overview
Table 167. Ipsen Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 168. Ipsen Cancer Treatment Drugs Product
Table 169. Ipsen Recent Developments/Updates
Table 170. AbbVie Company Information
Table 171. AbbVie Description and Business Overview
Table 172. AbbVie Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 173. AbbVie Cancer Treatment Drugs Product
Table 174. AbbVie Recent Developments/Updates
Table 175. Gilead Sciences Company Information
Table 176. Gilead Sciences Description and Business Overview
Table 177. Gilead Sciences Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 178. Gilead Sciences Cancer Treatment Drugs Product
Table 179. Gilead Sciences Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Cancer Treatment Drugs Distributors List
Table 183. Cancer Treatment Drugs Customers List
Table 184. Cancer Treatment Drugs Market Trends
Table 185. Cancer Treatment Drugs Market Drivers
Table 186. Cancer Treatment Drugs Market Challenges
Table 187. Cancer Treatment Drugs Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
Table 191. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cancer Treatment Drugs
Figure 2. Global Cancer Treatment Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Treatment Drugs Market Share by Type: 2024 & 2031
Figure 4. Chemotherapy Product Picture
Figure 5. Targeted Therapy Product Picture
Figure 6. Immunotherapy Product Picture
Figure 7. Hormonal Therapy (Biologic Therapy) Product Picture
Figure 8. Others Product Picture
Figure 9. Global Cancer Treatment Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Cancer Treatment Drugs Market Share by Application: 2024 & 2031
Figure 11. Blood Cancer
Figure 12. Breast Cancer
Figure 13. Gastrointestinal Cancer
Figure 14. Prostate Cancer
Figure 15. Respiratory or Lung Cancer
Figure 16. Others
Figure 17. Global Cancer Treatment Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Cancer Treatment Drugs Market Size (2020-2031) & (US$ Million)
Figure 19. Global Cancer Treatment Drugs Sales (2020-2031) & (K Pcs)
Figure 20. Global Cancer Treatment Drugs Average Price (USD/Pcs) & (2020-2031)
Figure 21. Cancer Treatment Drugs Report Years Considered
Figure 22. Cancer Treatment Drugs Sales Share by Manufacturers in 2024
Figure 23. Global Cancer Treatment Drugs Revenue Share by Manufacturers in 2024
Figure 24. Global 5 and 10 Largest Cancer Treatment Drugs Players: Market Share by Revenue in Cancer Treatment Drugs in 2024
Figure 25. Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Global Cancer Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 27. North America Cancer Treatment Drugs Sales Market Share by Country (2020-2031)
Figure 28. North America Cancer Treatment Drugs Revenue Market Share by Country (2020-2031)
Figure 29. U.S. Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Canada Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Europe Cancer Treatment Drugs Sales Market Share by Country (2020-2031)
Figure 32. Europe Cancer Treatment Drugs Revenue Market Share by Country (2020-2031)
Figure 33. Germany Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. France Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. U.K. Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Italy Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Russia Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Asia Pacific Cancer Treatment Drugs Sales Market Share by Region (2020-2031)
Figure 39. Asia Pacific Cancer Treatment Drugs Revenue Market Share by Region (2020-2031)
Figure 40. China Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Japan Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. South Korea Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. India Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Australia Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. China Taiwan Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Indonesia Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Thailand Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Malaysia Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Latin America Cancer Treatment Drugs Sales Market Share by Country (2020-2031)
Figure 50. Latin America Cancer Treatment Drugs Revenue Market Share by Country (2020-2031)
Figure 51. Mexico Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Brazil Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Argentina Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Middle East and Africa Cancer Treatment Drugs Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Country (2020-2031)
Figure 56. Turkey Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. UAE Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Global Sales Market Share of Cancer Treatment Drugs by Type (2020-2031)
Figure 60. Global Revenue Market Share of Cancer Treatment Drugs by Type (2020-2031)
Figure 61. Global Cancer Treatment Drugs Price (USD/Pcs) by Type (2020-2031)
Figure 62. Global Sales Market Share of Cancer Treatment Drugs by Application (2020-2031)
Figure 63. Global Revenue Market Share of Cancer Treatment Drugs by Application (2020-2031)
Figure 64. Global Cancer Treatment Drugs Price (USD/Pcs) by Application (2020-2031)
Figure 65. Cancer Treatment Drugs Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed